Drug-resistant tuberculosis in high-risk groups, Zimbabwe

Emerg Infect Dis. 2014 Jan;20(1):135-7. doi: 10.3201/eid2001.130732.

Abstract

To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.

Keywords: HIV/TB; MDR TB; Mycobacterium tuberculosis; Zimbabwe; antimicrobial resistance; bacteria; drug-resistant tuberculosis; mycobacteria; retreatment tuberculosis; tuberculosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Drug Resistance, Multiple, Bacterial*
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects*
  • Prevalence
  • Prospective Studies
  • Tuberculosis, Multidrug-Resistant / epidemiology*
  • Zimbabwe / epidemiology